MedTrace Logo

11C-PIB PET Study in MESA at Columbia University

NCT03981380 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2025-02-18

No results posted yet for this study

Summary

The investigators will conduct a study of brain positron emission tomography (PET) using 11C-PIB for the imaging of brain amyloid in 250 participants in the Multiethnic study of atherosclerosis (MESA) at Columbia University Irving Medical Center in New York City. Participants will be imaged only once with Pittsburgh Compound B (PIB) PET.

Conditions

Interventions

DRUG

11C-PIB

Participants will be injected with an intravenous bolus of up to 5-15mCi (370 MBq) (+/-10%) of \[11C\]PiB (over 5-10 seconds).

Sponsors & Collaborators

  • Wake Forest University

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • José A. Luchsinger

    lead OTHER

Principal Investigators

  • José Luchsinger, MD, MPH · Professor of Medicine and Epidemiology

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2024-02-05
Completion
2024-02-05
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03981380 on ClinicalTrials.gov